BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33046021)

  • 1. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
    Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
    BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24).
    Catic A; Kurtovic-Kozaric A; Johnson SH; Vasmatzis G; Pins MR; Kogan J
    Cancer Genet; 2017 Aug; 214-215():9-15. PubMed ID: 28595733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular features of metanephric adenoma and their values in differential diagnosis].
    Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
    [No Abstract]   [Full Text] [Related]  

  • 4. BRAF mutations in pediatric metanephric tumors.
    Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
    Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
    Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
    Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF mutations in metanephric adenoma of the kidney.
    Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S
    Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
    Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
    Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
    Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
    Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
    Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
    Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
    Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature.
    Rakheja D; Lian F; Tomlinson GE; Ewalt DH; Schultz RA; Margraf LR
    Pediatr Dev Pathol; 2005; 8(2):218-23. PubMed ID: 15747102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
    Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.
    Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S
    Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
    Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
    Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
    Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
    [No Abstract]   [Full Text] [Related]  

  • 18. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
    de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
    Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.